Clinical Trial Update: Study Evaluating Near-infrared Imaging Coupled With Indocyanine Green for Intraoperative Control of Resection Margins in ENT Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating near-infrared imaging with indocyanine green to guide intraoperative margins in head and neck cancer surgery is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Head and Neck Cancer | Phase 2 | Status: RECRUITING